Endocrine Pathology
Journal Impact IF - Analysis · Trend · Prediction · Ranking


New

Journal Impact IF

2019-2020

3.168

-5.9 %

Journal Impact IF Trend

Related Journals

Popular Journals

Endocrine Pathology

The 2019-2020 Journal Impact IF of Endocrine Pathology is 3.168, which is just updated in 2020.

Endocrine Pathology Impact Factor
Highest IF
3.366
Highest Journal Impact IF

The highest Journal Impact IF of Endocrine Pathology is 3.366.

Lowest IF
1.358
Lowest Journal Impact IF

The lowest Journal Impact IF of Endocrine Pathology is 1.358.

Total Growth Rate
133.3%
IF Total Growth Rate

The total growth rate of Endocrine Pathology IF is 133.3%.

Annual Growth Rate
14.8%
IF Annual Growth Rate

The annual growth rate of Endocrine Pathology IF is 14.8%.

Journal Impact IF Ranking

Subcategory Quartile Rank Percentile
Pathology and Forensic Medicine Q1 34/191

Pathology and Forensic Medicine 82%

Endocrinology, Diabetes and Metabolism Q2 75/217

Endocrinology, Diabetes and Metabolism 65%

Endocrinology Q2 52/118

Endocrinology 56%

Journal Impact IF Ranking

· In the Pathology and Forensic Medicine research field, the Quartile of Endocrine Pathology is Q1. Endocrine Pathology has been ranked #34 over 191 related journals in the Pathology and Forensic Medicine research category. The ranking percentile of Endocrine Pathology is around 82% in the field of Pathology and Forensic Medicine.
· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of Endocrine Pathology is Q2. Endocrine Pathology has been ranked #75 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of Endocrine Pathology is around 65% in the field of Endocrinology, Diabetes and Metabolism.
· In the Endocrinology research field, the Quartile of Endocrine Pathology is Q2. Endocrine Pathology has been ranked #52 over 118 related journals in the Endocrinology research category. The ranking percentile of Endocrine Pathology is around 56% in the field of Endocrinology.

Endocrine Pathology Impact Factor 2020-2021 Prediction

Endocrine Pathology Impact Factor Predition System

Endocrine Pathology Impact Factor Prediction System is now online. You can start share your valuable insights with the community.

Predict Check All Preditions
Total Publications
1302
Total Citations
21388

Annual Publication Volume

Annual Citation Record

International Collaboration Trend

Cited Documents Trend

Journal Impact IF History

Year Journal Impact IF
Year Journal Impact IF
2019-2020 3.168
2018-2019 3.366
2017-2018 2.541
2016-2017 1.936
2015-2016 1.817
2014-2015 1.757
2013-2014 1.644
2012-2013 1.6
2011-2012 1.358
Journal Impact IF History

· The 2019-2020 Journal Impact IF of Endocrine Pathology is 3.168
· The 2018-2019 Journal Impact IF of Endocrine Pathology is 3.366
· The 2017-2018 Journal Impact IF of Endocrine Pathology is 2.541
· The 2016-2017 Journal Impact IF of Endocrine Pathology is 1.936
· The 2015-2016 Journal Impact IF of Endocrine Pathology is 1.817
· The 2014-2015 Journal Impact IF of Endocrine Pathology is 1.757
· The 2013-2014 Journal Impact IF of Endocrine Pathology is 1.644
· The 2012-2013 Journal Impact IF of Endocrine Pathology is 1.6
· The 2011-2012 Journal Impact IF of Endocrine Pathology is 1.358

Publications Cites Dataset

Year Publications Citations
Year Publications Citations
1990 26 2
1991 32 20
1992 28 35
1993 33 31
1994 31 40
1995 39 93
1996 36 100
1997 38 151
1998 44 169
1999 42 202
2000 39 215
2001 43 225
2002 43 235
2003 39 321
2004 40 452
2005 42 583
2006 45 706
2007 33 699
2008 41 805
2009 42 1052
2010 43 1294
2011 41 1099
2012 39 1205
2013 42 1221
2014 66 1388
2015 62 1484
2016 48 1415
2017 52 1484
2018 48 1310
2019 41 1380
2020 56 1825
2021 8 147
Publications Cites Dataset

· The Endocrine Pathology has published 26 reports and received 2 citations in 1990.
· The Endocrine Pathology has published 32 reports and received 20 citations in 1991.
· The Endocrine Pathology has published 28 reports and received 35 citations in 1992.
· The Endocrine Pathology has published 33 reports and received 31 citations in 1993.
· The Endocrine Pathology has published 31 reports and received 40 citations in 1994.
· The Endocrine Pathology has published 39 reports and received 93 citations in 1995.
· The Endocrine Pathology has published 36 reports and received 100 citations in 1996.
· The Endocrine Pathology has published 38 reports and received 151 citations in 1997.
· The Endocrine Pathology has published 44 reports and received 169 citations in 1998.
· The Endocrine Pathology has published 42 reports and received 202 citations in 1999.
· The Endocrine Pathology has published 39 reports and received 215 citations in 2000.
· The Endocrine Pathology has published 43 reports and received 225 citations in 2001.
· The Endocrine Pathology has published 43 reports and received 235 citations in 2002.
· The Endocrine Pathology has published 39 reports and received 321 citations in 2003.
· The Endocrine Pathology has published 40 reports and received 452 citations in 2004.
· The Endocrine Pathology has published 42 reports and received 583 citations in 2005.
· The Endocrine Pathology has published 45 reports and received 706 citations in 2006.
· The Endocrine Pathology has published 33 reports and received 699 citations in 2007.
· The Endocrine Pathology has published 41 reports and received 805 citations in 2008.
· The Endocrine Pathology has published 42 reports and received 1052 citations in 2009.
· The Endocrine Pathology has published 43 reports and received 1294 citations in 2010.
· The Endocrine Pathology has published 41 reports and received 1099 citations in 2011.
· The Endocrine Pathology has published 39 reports and received 1205 citations in 2012.
· The Endocrine Pathology has published 42 reports and received 1221 citations in 2013.
· The Endocrine Pathology has published 66 reports and received 1388 citations in 2014.
· The Endocrine Pathology has published 62 reports and received 1484 citations in 2015.
· The Endocrine Pathology has published 48 reports and received 1415 citations in 2016.
· The Endocrine Pathology has published 52 reports and received 1484 citations in 2017.
· The Endocrine Pathology has published 48 reports and received 1310 citations in 2018.
· The Endocrine Pathology has published 41 reports and received 1380 citations in 2019.
· The Endocrine Pathology has published 56 reports and received 1825 citations in 2020.
· The Endocrine Pathology has published 8 reports and received 147 citations in 2021.
· The total publications of Endocrine Pathology is 1302.
· The total citations of Endocrine Pathology is 21388.

What is Impact Factor?

The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations of articles published in the last two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values.

Endocrine Pathology | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Impact Factor of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Impact Factor are often deemed to be more important than those with lower ones. The Endocrine Pathology Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Endocrine Pathology during the two preceding years (2018-2019). Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1, are known zero values. Journals that are indexed starting with a volume other than the first volume will not get an impact factor until they have been indexed for three years. Occasionally, Journal Citation Reports assigns an impact factor to new journals with less than two years of indexing, based on partial citation data. The calculation always uses two complete and known years of item counts, but for new titles one of the known counts is zero. Annuals and other irregular publications sometimes publish no items in a particular year, affecting the count. The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Endocrine Pathology.

History

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI). Impact factors are calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson ISI was sold to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Use

The impact factor is used to compare different journals within a certain field. The Web of Science indexes more than 11,500 science and social science journals. Journal impact factors are often used to evaluate the merit of individual articles and individual researchers. This use of impact factors was summarised by Hoeffel:

Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the best journals in our specialty....In conclusion, prestigious journals publish papers of high level. Therefore, their impact factor is high, and not the contrary.

Eugene Garfield

In brief, Impact factors may be used by:
  • Authors to decide where to submit an article for publication.
  • Libraries to make collection development decisions
  • Academic departments to assess academic productivity
  • Academic departments to make decisions on promotion and tenure.
As impact factors are a journal-level metric, rather than an article- or individual-level metric, this use is controversial. Garfield agrees with Hoeffel,but warns about the "misuse in evaluating individuals" because there is "a wide variation [of citations] from article to article within a single journal". Other things to consider about Impact Factors:
  • Many journals do not have an impact factor.
  • The impact factor cannot assess the quality of individual articles. Even if citations were evenly distributed among articles, the impact factor would only measure the interests of other researchers in an article, not its importance and usefulness.
  • Only research articles, technical notes and reviews are “citable” items. Editorials, letters, news items and meeting abstracts are “non-citable items”.
  • Only a small percentage of articles are highly cited and they are found in a small subset of journals. This small proportion accounts for a large percentage of citations.
  • Controversial papers, such as those based on fraudulent data, may be highly cited, distorting the impact factor of a journal.
  • Citation bias may exist. For example, English language resources may be favoured. Authors may cite their own work.
Moreover, informed and careful use of these impact data is essential, and should be based on a thorough understanding of the methodology used to generate impact factors. There are controversial aspects of using impact factors:
  • It is not clear whether the number of times a paper is cited measures its actual quality.
  • Some databases that calculate impact factors fail to incorporate publications including textbooks, handbooks and reference books.
  • Certain disciplines have low numbers of journals and usage. Therefore, one should only compare journals or researchers within the same discipline.
  • Review articles normally are cited more often and therefore can skew results.
  • Self-citing may also skew results.
  • Some resources used to calculate impact factors have inadequate international coverage.
  • Editorial policies can artificially inflate an impact factor.
Impact factors have often been used in advancement and tenure decision-making. Many recognize that this is a coarse tool for such important decisions, and that a multitude of factors should be taken into account in these deliberations. When considering the use of the impact factor (IF), keep these aspects in mind:
  • IF analysis is limited to citations from the journals indexed by the Web of Science/Web of Knowledge. Currently, the Web of Science indexes only 8621 journals across the full breadth of the sciences, and just 3121 in the social sciences.
  • A high IF/citation rate says nothing about the quality -- or even, validity -- of the references being cited. Notorious or even retracted articles often attract a lot of attention, hence a high number of citations. The notority related to the first publication on "cold fusion" is one such example.
  • Journals that publish more "review articles" are often found near the top of the rankings. While not known for publishing new, creative findings, these individual articles tend to be heavily cited.
  • The IF measures the average number of citations to articles in the journal -- given this, a small number of highly-cited articles will skew the figure.
  • It takes several years for new journals to be added to the list of titles indexed by the Web of Science/Web of Knowledge, so these newer titles will be under-represented.
  • It's alleged that journal editors have learned to "game" the system, encouraging authors to cite their works previously published in the same journal.
Comparing Journals Across Disciplines? Not a good idea! Using Impact Factors within a given discipline should only be done with great care, as described above. Using impact factor data to compare journals across disciplines is even more problematic. Here are some of the reasons:
  • Disciplines where older literature is still referenced, such as Chemistry and Mathematics, offer challenges to the methodolgy since older citations (older than two years) are not used to calculate the impact factor for a given journal. (Five-year impact factor analysis, which can be calculated using the Journal Citation Index database, helps smooth out this problem only to some degree.)
  • Different disciplines have different practices regarding tendency to cite larger numbers of references. Higher overall citation rates will bump upward impact factor measurements.
  • Where it's common for large numbers of authors to collaborate on a single paper, such as in Physics, the tendency of authors to cite themselves (and in this case, more authors) will result in increased citation rates.

Pros and Cons of the Impact Factor

Pros:

  • A vetted, established metric for measuring journal impact within a discipline.
  • Designed to eliminate bias based on journal size and frequency.
Cons:
  • Individual articles makes an uneven contribution to overall Impact Factor.
  • Impact Factor does not account for certain things, things like context (postive or negative citaion) and intentionality (self-citation).
  • The metric is proprietary to and bound by the contents of the Thomson Reuters database.
  • Citations, on which the Impact Factor is based, count for less than 1% of an article's overall use.

Criticism

Numerous critiques have been made regarding the use of impact factors. A 2007 study noted that the most fundamental flaw is that impact factors present the mean of data that are not normally distributed, and suggested that it would be more appropriate to present the median of these data. There is also a more general debate on the validity of the impact factor as a measure of journal importance and the effect of policies that editors may adopt to boost their impact factor (perhaps to the detriment of readers and writers). Other criticism focuses on the effect of the impact factor on behavior of scholars, editors and other stakeholders. Others have made more general criticisms, arguing that emphasis on impact factor results from negative influence of neoliberal policies on academia claiming that what is needed is not just replacement of the impact factor with more sophisticated metrics for science publications but also discussion on the social value of research assessment and the growing precariousness of scientific careers in higher education.
Experts stress that there are limitations in using impact factors to evaluate a scholar's work. There are many reasons cited for not relying on impact factor alone to evaluate the output of a particular individual. Among these are the following:

  • A single factor is not sufficient for evaluating an author's work.
  • Journal values are meaningless unless compared within the same discipline. Impact factors vary among disciplines.
  • The impact factor was originally devised to show the impact of a specific journal, not a specific scholar. The quality and impact of the author's work may extend beyond the impact of a particular journal.
According to Jim Testa, a researcher for ThomsonReuters Scientific, the most widespread misuse of the Impact Factor is to evaluate the work of an individual author (instead of a journal). "To say that because a researcher is publishing in a certain journal, he or she is more influential or deserves more credit is not necessarily true. There are many other variables to consider." (interview 6/26/2008 in Thomson Reuters blog entry)

Endocrine Pathology
Journal Profile

About

Endocrine Pathology publishes original articles on clinical and basic aspects of endocrine disorders. Work with animals or in vitro techniques is acceptable if it is relevant to human normal or abnormal endocrinology. Manuscripts will be considered for publication in the form of original articles, case reports, clinical case presentations, reviews, and descriptions of techniques. Submission of a paper implies that it reports unpublished work, except in abstract form, and is not being submitted simultaneously to another publication. Accepted manuscripts become the sole property of Endocrine Pathology and may not be published elsewhere without written consent from the publisher. All articles are subject to review by experienced referees. The Editors and Editorial Board judge manuscripts suitable for publication, and decisions by the Editors are final. None

Highly Cited Keywords

ISSN
1046-3976
ISSN

The ISSN of Endocrine Pathology is 1046-3976 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
1559-0097
ISSN (Online)

The ISSN (Online) of Endocrine Pathology is 1559-0097 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Publisher
Humana Press
Publisher

Endocrine Pathology is published by Humana Press .

Publication Frequency
Quarterly
Publication Frequency

Endocrine Pathology publishes reports Quarterly .

Coverage
1990 - Present
Coverage

The Publication History of Endocrine Pathology covers 1990 - Present .

Open Access
NO
Open Access

Endocrine Pathology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Publication Fee
Publication Fee

There is no publication fee for submiting manuscript to Endocrine Pathology. Endocrine Pathology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

Language
English
Language

The language of Endocrine Pathology is English .

Country/Region
United States
Country/Region

The publisher of Endocrine Pathology is Humana Press , which locates in United States .

Selected Articles

Full Title Authors
Full Title Authors
Fit-for-Purpose Immunohistochemical Biomarkers Emina Torlakovic · Emina Torlakovic · Emina Torlakovic
Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms Ozgur Mete · Sylvia L. Asa · Thomas J. Giordano · Mauro Papotti · Hironobu Sasano · Marco Volante · Marco Volante
Application of Strict Criteria for Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Encapsulated Follicular Variant Papillary Thyroid Carcinoma: a Retrospective Study of 50 Tumors Previously Diagnosed as Follicular Variant PTC Kimberly Point du Jour · Alessandra C. Schmitt · Amy Y. Chen · Christopher C. Griffith · Christopher C. Griffith · Christopher C. Griffith
RNA-Seq Analysis of Islets to Characterise the Dedifferentiation in Type 2 Diabetes Model Mice db/db Abraham Neelankal John · Abraham Neelankal John · Ramesh Ram · Fang-Xu Jiang · Fang-Xu Jiang
Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice: Perspectives for Surgical Pathology and Cytopathology Andrey Bychkov · Chan Kwon Jung · Zhiyan Liu · Kennichi Kakudo · Kennichi Kakudo
An International Interobserver Variability Reporting of the Nuclear Scoring Criteria to Diagnose Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: a Validation Study Lester D. R. Thompson · David N. Poller · Kennichi Kakudo · Raoul Burchette · Yuri E. Nikiforov · Raja R. Seethala · Raja R. Seethala
LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases Maria José Carregosa Pinheiro dos Santos · André Uchimura Bastos · Vitor Rodrigues da Costa · Rosana Delcelo · Susan C. Lindsey · Gabriel Avelar Colozza-Gama · Hongzhuang Peng · Frank J. Rauscher · Gisele Oler · Janete M. Cerutti · Janete M. Cerutti
Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures Vincent Cracolici · Ibro Mujacic · Sabah Kadri · Mir Alikhan · Nifang Niu · Jeremy P. Segal · Lauren Rosen · David H. Sarne · Adam Morgan · Samy Desouky · Nicole A. Cipriani · Nicole A. Cipriani
IgG4-Associated Adrenalitis—a Case Report Wolfgang Saeger · Bernd Lohe · Christina Luise Engels · Ulrike Werner · Ulrike Werner
Positivity for GATA3 and TTF-1 (SPT24), and Negativity for Monoclonal PAX8 Expand the Biomarker Profile of the Solid Cell Nests of the Thyroid Gland Hasan Gucer · Ozgur Mete · Ozgur Mete · Ozgur Mete · Ozgur Mete
Comparison of Monitor-Image and Printout-Image Methods in Ki-67 Scoring of Gastroenteropancreatic Neuroendocrine Tumors Fatih Mert Doğukan · Banu Yılmaz Özgüven · Rabia Dogukan · Fevziye Kabukcuoglu · Fevziye Kabukcuoglu
Comparison Study of the Adequacy and Pain Scale of Ultrasound-Guided Fine-Needle Aspiration of Solid Thyroid Nodules with a 21- or 23-Gauge Needle for Liquid-Based Cytology: a Single-Center Study Soo Jin Jung · Dong Wook Kim · Hye Jin Baek · Hye Jin Baek
A Young Male with Parafibromin-Deficient Parathyroid Carcinoma Due to a Rare Germline HRPT2/CDC73 Mutation Alisha Kapur · Narendra Singh · Ozgur Mete · Robert A. Hegele · I. George Fantus · I. George Fantus
Immunohistochemical Biomarkers in Thyroid Pathology Zubair W. Baloch · Ozgur Mete · Ozgur Mete · Sylvia L. Asa · Sylvia L. Asa · Sylvia L. Asa
Long Non-coding RNA Linc-ROR Is Upregulated in Papillary Thyroid Carcinoma Ranran Zhang · Heather Hardin · Wei Huang · Darya Buehler · Ricardo V. Lloyd · Ricardo V. Lloyd
EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma Michael C. Topf · Zi-Xuan Wang · Kevin Furlong · Jeffrey L. Miller · Madalina Tuluc · Edmund A. Pribitkin · Edmund A. Pribitkin
Solid Cell Nests Within a Parathyroid Gland—Report of an Exceptional Case C. Christofer Juhlin · Inga-Lena Nilsson · Anders Höög · Anders Höög
The Value of Negative Diagnosis in Thyroid Fine-Needle Aspiration: a Retrospective Study with Histologic Follow-Up Rita Abi-Raad · Manju L. Prasad · Rebecca Baldassari · Kevin Schofield · Glenda G. Callender · David Chhieng · Adebowale J. Adeniran · Adebowale J. Adeniran
Immunohistochemical Biomarkers in Diagnosis of Hematolymphoid Neoplasms of Endocrine Organs Isinsu Kuzu · Ahmet Dogan · Ahmet Dogan
Editorial: Special Issue on Immunohistochemical Biomarkers in Endocrine Pathology Lori A. Erickson · Ozgur Mete · Ozgur Mete
Clinical and Pathologic Characteristics of Pulmonary Carcinoid Tumors in Central and Peripheral Locations George Papaxoinis · Angela Lamarca · Anne Marie Quinn · Wasat Mansoor · Daisuke Nonaka · Daisuke Nonaka
Old, New, and Emerging Immunohistochemical Markers in Pheochromocytoma and Paraganglioma Veronica K.Y. Cheung · Anthony J. Gill · Angela Chou · Angela Chou
A Case of Gastric Neuroendocrine Neoplasm with Mixed Grade: a Distinct Type ofHigh-grade Well-Differentiated Neuroendocrine Neoplasm Elia Guadagno · Gaetano Luglio · Alessandro Iacobelli · Giorgio Borrelli · Antonio Castaldi · Gaetano De Rosa · Marialaura Del Basso De Caro · Marialaura Del Basso De Caro
Immunohistochemistry in Diagnostic Parathyroid Pathology Lori A. Erickson · Ozgur Mete · Ozgur Mete
Immunohistochemical Biomarkers of Mesenchymal Neoplasms in Endocrine Organs: Diagnostic Pitfalls and Recent Discoveries Yin P. Hung · Jason L. Hornick · Jason L. Hornick
Clinical Impact of p27 Kip1 and CaSR Expression on Primary Hyperparathyroidism Gozde Sengul Aycicek · Berna Imge Aydogan · Mustafa Sahin · Cevriye Cansız Ersöz · Serpil Dizbay Sak · Nilgun Baskal · Nilgun Baskal
Pancreatic Neuroendocrine Tumor Producing Insulin and Vasopressin Omalkhaire M. Alshaikh · Omalkhaire M. Alshaikh · Ju-Yoon Yoon · Bryan Chan · Monika K. Krzyzanowska · Jagdish Butany · Sylvia L. Asa · Shereen Ezzat · Shereen Ezzat
Expanding the Spectrum of Colonic Manifestations in Tuberous Sclerosis: L-Cell Neuroendocrine Tumor Arising in the Background of Rectal PEComa David L. Kolin · Kai Duan · Bo Ngan · Bo Ngan · J. Ted Gerstle · Monika K. Krzyzanowska · Gino R. Somers · Gino R. Somers · Ozgur Mete · Ozgur Mete · Ozgur Mete · Ozgur Mete
The Prevalence of Extranodal Extension in Papillary Thyroid Cancer Based on the Size of the Metastatic Node: Adverse Histologic Features Are Not Limited to Larger Lymph Nodes Meghan E. Rowe · Umut Ozbek · Rosalie A. Machado · Lauren E. Yue · Juan C. Hernandez-Prera · Alessandro Valentino · Muhammad Qazi · Margaret Brandwein-Weber · Xulei Liu · Bruce M. Wenig · Mark L. Urken · Mark L. Urken
TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma Johan O. Paulsson · Anton Olander · Felix Haglund · Jan Zedenius · C. Christofer Juhlin · C. Christofer Juhlin
Antidepressant-Related Black Thyroid Jean-Luc Barras · Rossella Sarro · Massimo Bongiovanni · Stefano La Rosa · Stefano La Rosa
Reclassification as NIFTP: a Retrospective Review in a Single Institution with an Emphasis on Workload Kevin O’Hare · E. O’Regan · A. Khattak · M. L. Healy · M. Toner · M. Toner
TEKT4 Promotes Papillary Thyroid Cancer Cell Proliferation, Colony Formation, and Metastasis through Activating PI3K/Akt Pathway Zhouci Zheng · Xiao-Fen Zhou · Ye-Feng Cai · En-Dong Chen · Xiaohua Zhang · Ouchen Wang · Qing-Xuan Wang · Haiguang Liu · Haiguang Liu
Papillary Thyroid Microcarcinoma: Reclassification to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): a Retrospective Clinicopathologic Study Khurram Shafique · Virginia A. LiVolsi · Kathleen T. Montone · Zubair W. Baloch · Zubair W. Baloch
Cervical Lymph Node Fine-Needle Aspiration and Needle-Wash Thyroglobulin Reflex Test for Papillary Thyroid Carcinoma Xiaotun Zhang · Joshua M. Howell · Yajue Huang · Yajue Huang
Clinically Relevant Prognostic Parameters in Differentiated Thyroid Carcinoma Tyler Janovitz · Justine A. Barletta · Justine A. Barletta
Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages Ozgur Mete · Omalkhaire M. Alshaikh · Amber Cintosun · Shereen Ezzat · Sylvia L. Asa · Sylvia L. Asa
Catecholamine-Synthesizing Enzymes in Pheochromocytoma and Extraadrenal Paraganglioma Sachiko Konosu-Fukaya · Kei Omata · Yuta Tezuka · Yoshikiyo Ono · Yayoi Aoyama · Fumitoshi Satoh · Fumiyoshi Fujishima · Hironobu Sasano · Yasuhiro Nakamura · Yasuhiro Nakamura
Detection of Molecular Alterations in Taiwanese Patients with Medullary Thyroid Cancer Using Whole-Exome Sequencing Ya-Sian Chang · Chun-Chi Chang · Hsi-Yuan Huang · Chien-Yu Lin · Kun-Tu Yeh · Jan-Gowth Chang · Jan-Gowth Chang · Jan-Gowth Chang
Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis Daniel Lubin · Ezra Baraban · Amanda Lisby · Sahar Jalali-Farahani · Paul J. Zhang · Virginia A. LiVolsi · Virginia A. LiVolsi
Grade 3 Neuroendocrine Tumor (G3 NET) in a Background of Multiple Serotonin Cell Neoplasms of the Ileum Associated with Carcinoid Syndrome and Aggressive Behavior Francesca Capuano · Oneda Grami · Luigi Pugliese · Marco Paulli · Andrea Pietrabissa · Enrico Solcia · Alessandro Vanoli · Alessandro Vanoli
Histologic Outcome of Indeterminate Thyroid Nodules Classified at Low or High Risk Pierpaolo Trimboli · Franco Fulciniti · Elisabetta Merlo · Jessica Barizzi · Luca Mazzucchelli · Luca Giovanella · Luca Giovanella
Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) Kyle C. Strickland · Markus Eszlinger · Ralf Paschke · Trevor E. Angell · Erik K. Alexander · Ellen Marqusee · Matthew A. Nehs · Vickie Y. Jo · Alarice Lowe · Marina Vivero · Monica Hollowell · Xiaohua Qian · Tad J. Wieczorek · Christopher A. French · Lisa A. Teot · Edmund S. Cibas · Neal I. Lindeman · Jeffrey F. Krane · Justine A. Barletta · Justine A. Barletta
Immunohistochemical Biomarkers in Pituitary Pathology Sylvia L. Asa · Sylvia L. Asa · Ozgur Mete · Ozgur Mete · Ozgur Mete
Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms Silvia Uccella · Stefano La Rosa · Marco Volante · Mauro Papotti · Mauro Papotti
PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma Matthew W. Rosenbaum · Benjamin J. Gigliotti · Sara I. Pai · Sareh Parangi · Heather Wachtel · Mari Mino-Kenudson · Viswanath Gunda · William C. Faquin · William C. Faquin
Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20 Sounak Gupta · Divya Sahu · John S. Bomalaski · Igor Frank · Stephen A. Boorjian · Prabin Thapa · John C. Cheville · Donna E. Hansel · Donna E. Hansel
Ki67 Proliferative Index in Carcinoid Tumors Involving Ovary Xiaotun Zhang · Andrea Jones · Sarah M. Jenkins · Yajue Huang · Yajue Huang
Cytomorphological Analysis of Thyroid Nodules Diagnosed as Follicular Variant of Papillary Thyroid Carcinoma: a Fine Needle Aspiration Study of Diagnostic Clues in 42 Cases and the Impact of Using Bethesda System in Reporting—an Institutional Experience Levent Trabzonlu · Nadir Paksoy · Nadir Paksoy
Comparison of Consecutive Results from Fine Needle Aspiration and Core Needle Biopsy in Thyroid Nodules Soon-Hyun Ahn · So-Yeon Park · Sang Il Choi · Sang Il Choi
Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours Alfred King-Yin Lam · Alfred King-Yin Lam
Immune Escape Mechanism is Impaired in the Microenvironment of Thyroid Lymph Node Metastasis Lucas Leite Cunha · Suely Nonogaki · Fernando Augusto Soares · José Vassallo · Laura Sterian Ward · Laura Sterian Ward
Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel–Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127) Sounak Gupta · Jun Zhang · Dragana Milosevic · John R. Mills · Stefan K. Grebe · Steven C. Smith · Lori A. Erickson · Lori A. Erickson
Novel Cause of Black Thyroid: Intraoperative Use of Indocyanine Green Ryan S. Jackson · Ryan S. Jackson
Differences in Clinical Features Between Subcategories ofAtypia/Follicular Lesion of Undetermined Significance Seong Dong Kim · Seung Hoon Han · Woo-Jin Jeong · Hyojin Kim · Soon Hyun Ahn · Soon Hyun Ahn
MEN2 Syndrome-Related Medullary Thyroid Carcinoma with Focal Tyrosine Hydroxylase Expression: Does It Represent a Hybrid Cellular Phenotype or Functional State of Tumor Cells? Ozgur Mete · Ozgur Mete · Ozgur Mete · Ahmed Essa · Anil Bramdev · Navendren Govender · Runjan Chetty · Runjan Chetty · Runjan Chetty
Ovarian Adrenal Rest Tumors Undetected by Imaging Studies and Identified at Surgery in Three Females with Congenital Adrenal Hyperplasia Unresponsive to Increased Hormone Therapy Dosage Huadong Chen · Li-e Huang · Zhi-hai Zhong · Zhe Su · Hong Jiang · Jing Zeng · Juncheng Liu · Juncheng Liu
Adrenal Teratoma: a Case Series and Review of the Literature Eric J. Kuo · Anthony Sisk · Zhiming Yang · Jiaoti Huang · Michael W. Yeh · Masha Livhits · Masha Livhits
Decreased TAp63 and ΔNp63 mRNA Levels in Most Human Pituitary Adenomas Are Correlated with Notch3/Jagged1 Relative Expression Lisiane Cervieri Mezzomo · Frederico Giacomoni Pesce · Josenel Maria Barcelos Marçal · Taiana Haag · Nelson Pires Ferreira · Júlia Fernanda Semmelmann Pereira Lima · Carolina Garcia Soares Leães · Miriam da Costa Oliveira · Maria Beatriz da Fonte Kohek · Maria Beatriz da Fonte Kohek
Immunoglobulin G4 (IgG4)-Related Hypophysitis Fabio Rotondo · Amro Qaddoura · Luis V. Syro · Jason Karamchandani · David G. Munoz · Mariam J. Arroyave · William P. Ospina · Michael D. Cusimano · Kalman Kovacs · Kalman Kovacs
Detecting N-RAS Q61R Mutated Thyroid Neoplasias by Immunohistochemistry Anna Crescenzi · Franco Fulciniti · Massimo Bongiovanni · Luca Giovanella · Pierpaolo Trimboli · Pierpaolo Trimboli
Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen—a Possible Novel Therapeutic Target Maureen D. Moore · Suraj Panjwani · Rashmi Mathew · Michael J. Crowley · Yifang Liu · Anna Aronova · Brendan M. Finnerty · Rasa Zarnegar · Thomas J. Fahey · Theresa Scognamiglio · Theresa Scognamiglio
Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours George Papaxoinis · Daisuke Nonaka · Ciara O’Brien · Benjamin Sanderson · Piotr Krysiak · Wasat Mansoor · Wasat Mansoor
Pathological and Genetic Characterization of Bilateral Adrenomedullary Hyperplasia in a Patient with Germline MAX Mutation Pauline Romanet · Carole Guerin · Pascal Pedini · Wassim Essamet · Frederic Castinetti · F. Sebag · Philippe Roche · Alberto Cascón · Arthur S. Tischler · Karel Pacak · Anne Barlier · David Taïeb · David Taïeb
The RET E616Q Variant is a Gain of Function Mutation Present in a Family with Features of Multiple Endocrine Neoplasia 2A William Grey · Rosaline Hulse · Anna Yakovleva · Dilyana Genkova · Benjamin Whitelaw · Ellen Solomon · Salvador Diaz-Cano · Louise Izatt · Louise Izatt · Louise Izatt
Teratoma of the Sellar Region: a Case Report Wolfgang Saeger · Azadeh Ebrahimi · Rudi Beschorner · Hildegard Spital · Jürgen Honegger · Waldemar Wilczak · Waldemar Wilczak
Pancreatic Struma with Papillary Thyroid Carcinoma: a Diagnostic Dilemma Jerry Liu · Michael Marcaccio · J. E. M. Young · Tariq Aziz · Josephine Wat · Sylvia L. Asa · Sylvia L. Asa
Diagnosis and Treatment of Metastases to the Thyroid Gland: a Meta-Analysis Patrizia Straccia · Claudia Mosseri · Chiara Brunelli · Esther Diana Rossi · Celestino Pio Lombardi · Alfredo Pontecorvi · Guido Fadda · Guido Fadda
Xanthomatous Hypophysitis Is Associated with Ruptured Rathkes Cleft Cyst Kai Duan · Kai Duan · Sylvia L. Asa · Sylvia L. Asa · Sylvia L. Asa · Daniel A. Winer · Daniel A. Winer · Zadeh Gelareh · Zadeh Gelareh · Fred Gentili · Fred Gentili · Ozgur Mete · Ozgur Mete · Ozgur Mete · Ozgur Mete
A Somatic HIF2α Mutation-Induced Multiple and Recurrent Pheochromocytoma/Paraganglioma with Polycythemia: Clinical Study with Literature Review Qiuli Liu · Yan Wang · Dali Tong · Gaolei Liu · Wenqiang Yuan · Jun Zhang · Jin Ye · Yao Zhang · Gang Yuan · Qingxing Feng · Dianzheng Zhang · Jun Jiang · Jun Jiang
Dopamine-Secreting Paraganglioma in the Retroperitoneum Yusuke Matsuda · Noriko Kimura · Takanobu Yoshimoto · Yoshihiro Sekiguchi · Junzo Tomoishi · Ichiro Kasahara · Yoshihito Hara · Yoshihiro Ogawa · Yoshihiro Ogawa
Frequent BRAFV600E and Absence of TERT Promoter Mutations Characterize Sporadic Pediatric Papillary Thyroid Carcinomas in Japan Naoki Oishi · Tetsuo Kondo · Tadao Nakazawa · Kunio Mochizuki · Tomohiro Inoue · Kazunari Kasai · Ippei Tahara · Tomonori Yabuta · Mitsuyoshi Hirokawa · Akira Miyauchi · Ryohei Katoh · Ryohei Katoh
Tissue Expression and Pharmacological In Vitro Analyses of mTOR and SSTR Pathways in Adrenocortical Carcinoma Antonina Germano · Ida Rapa · Eleonora Duregon · Arianna Votta · Jessica Giorcelli · Consuelo Buttigliero · Giorgio V. Scagliotti · Marco Volante · Massimo Terzolo · Mauro Papotti · Mauro Papotti
The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas Kristine S. Wong · Kyle C. Strickland · Trevor E. Angell · Matthew A. Nehs · Erik K. Alexander · Edmund S. Cibas · Jeffrey F. Krane · Brooke E. Howitt · Justine A. Barletta · Justine A. Barletta
Adrenocortical Carcinoma Arising in an Adrenal Rest: a Case Report and Review of the Literature Kristine M. Cornejo · Kristine M. Cornejo · Henrietta Afari · Peter M. Sadow · Peter M. Sadow
Pituitary Carcinoma in a Patient with an SDHB Mutation Nicola Tufton · Federico Roncaroli · Irene Hadjidemetriou · Mary N. Dang · Judit Dénes · Leonardo Guasti · Maria Thom · Michael J. Powell · Stephanie Baldeweg · Naomi Fersht · Márta Korbonits · Márta Korbonits
Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Historical Context, Diagnosis, and Future Challenges Bin Xu · Giovanni Tallini · Ronald Ghossein · Ronald Ghossein
Depletion of Beta Cell Intranuclear Rodlets in Human Type II Diabetes Yi Yuan Zhou · Soufiane El Hallani · Fady K. Balaa · Waleed M. Mohammad · Douglas A. Gray · John Woulfe · John Woulfe
Analysis of miR-96 and miR-133a Expression in Gastrointestinal Neuroendocrine Neoplasms Rakesh Mandal · Heather Hardin · Rebecca M. Baus · William M. Rehrauer · Ricardo V. Lloyd · Ricardo V. Lloyd
Hobnail Variant of Papillary Thyroid Carcinoma: a Literature Review Francesca Ambrosi · Alberto Righi · Costantino Ricci · Lori A. Erickson · Ricardo V. Lloyd · Sofia Asioli · Sofia Asioli
Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas Julieann C. Lee · Melike Pekmezci · Jonathan L. Lavezo · Hannes Vogel · Laurence Katznelson · Merav Fraenkel · Griffith R. Harsh · Mohanpal S. Dulai · Arie Perry · Tarik Tihan · Tarik Tihan
Calcitonin-Producing Neuroendocrine Neoplasms of the Pancreas: Clinicopathological Study of 25 Cases and Review of the Literature Silvia Uccella · Annika Blank · Roberta Maragliano · Fausto Sessa · Aurel Perren · Stefano La Rosa · Stefano La Rosa
Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase Sounak Gupta · Jun Zhang · Lori A. Erickson · Lori A. Erickson
Overview of the 2017 WHO Classification of Pituitary Tumors Ozgur Mete · Ozgur Mete · Ozgur Mete · M. Beatriz S. Lopes · M. Beatriz S. Lopes
Familial Papillary Thyroid Carcinoma (FPTC): a Retrospective Analysis in a Sample of the Bulgarian Population for a 10-Year Period Kalin Vidinov · Dragomira Nikolova · Dragomira Nikolova
Disorganized Steroidogenesis in Adrenocortical Carcinoma, a Case Study Toyoyoshi Uchida · Koshiro Nishimoto · Koshiro Nishimoto · Yuki Fukumura · Miki Asahina · Hiromasa Goto · Yui Kawano · Fumitaka Shimizu · Akira Tsujimura · Tsugio Seki · Kuniaki Mukai · Yasuaki Kabe · Makoto Suematsu · Celso E. Gomez-Sanchez · Takashi Yao · Shigeo Horie · Hirotaka Watada · Hirotaka Watada
Sarcomatoid Adrenal Carcinoma: Case Report with Contribution to Pathogenesis Wolfgang Saeger · Werner Mohren · Matthias Behrend · Peter Iglauer · Waldemar Wilczak · Waldemar Wilczak
MALAT1 Long Non-coding RNA Expression in Thyroid Tissues: Analysis by In Situ Hybridization and Real-Time PCR Ranran Zhang · Heather Hardin · Wei Huang · Jidong Chen · Sofia Asioli · Alberto Righi · Francesca Maletta · Anna Sapino · Ricardo V. Lloyd · Ricardo V. Lloyd
TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma Eun Ji Oh · Sohee Lee · Ja Seong Bae · Yourha Kim · Sora Jeon · Chan Kwon Jung · Chan Kwon Jung
Pathology of Human Pheochromocytoma and Paraganglioma Xenografts in NSG Mice James F. Powers · Karel Pacak · Arthur S. Tischler · Arthur S. Tischler
Malignancy in Pheochromocytoma or Paraganglioma: Integrative Analysis of 176 Cases in TCGA Yong Joon Suh · Ji-Young Choe · Hyo Jin Park · Hyo Jin Park
Neuroendocrine Tumors of the Breast Daniel W. Visscher · Saba Yasir · Saba Yasir
Gangliocytic Paraganglioma: a Diagnostic Pitfall of Rare Neuroendocrine Tumor Yoichiro Okubo · Yoichiro Okubo
Images in Endocrine Pathology: Unique Composite Adrenal Adenomatoid Tumor, Ganglioneuroma, Myelolipoma, and Cortical Nodular Hyperplasia Eleonora Duregon · Marco Volante · Stefano Guzzetti · Ida Rapa · Simona Vatrano · Mauro Papotti · Mauro Papotti
A Novel TP53 Mutation Associated with TWIST1 and SIP1 Expression in an Aggressive Adrenocortical Carcinoma Daniel Alves Bulzico · Davi Coe Torres · Gerson Moura Ferreira · Bruno Ricardo Barreto Pires · Paulo Antônio Silvestre de Faria · Rocio Hassan · Eliana Abdelhay · Mario Vaisman · Leonardo Vieira Neto · Leonardo Vieira Neto
TFE3-Expressing Perivascular Epithelioid Cell Neoplasm (PEComa) of the Sella Turcica Martin D. Hyrcza · Martin D. Hyrcza · Daniel A. Winer · Daniel A. Winer · Daniel A. Winer · Mary Shago · Karolyn Au · Gelareh Zadeh · Gelareh Zadeh · Sylvia L. Asa · Sylvia L. Asa · Sylvia L. Asa · Ozgur Mete · Ozgur Mete · Ozgur Mete · Ozgur Mete
Metastatic Follicular Thyroid Carcinoma and the Primary Thyroid Gross Examination: Institutional Review of Cases from 1990 to 2015 Krzysztof Glomski · Vania Nose · William C. Faquin · William C. Faquin · Peter M. Sadow · Peter M. Sadow · Peter M. Sadow
Analysis of Newly Identified and Rare Synonymous Genetic Variants in the RET Gene in Patients with Medullary Thyroid Carcinoma in Polish Population Maria Sromek · Małgorzata Czetwertyńska · Magdalena Tarasińska · Aneta Janiec-Jankowska · Renata Zub · Maria Ćwikła · Dorota Nowakowska · Magdalena Chechlinska · Magdalena Chechlinska
Long-Term Outcomes of Patients with Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) ≥4 cm Treated Without Radioactive Iodine Pedro Weslley Rosario · Pedro Weslley Rosario
Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm Adam Covach · Sanjay Patel · Heather Hardin · Ricardo V. Lloyd · Ricardo V. Lloyd
Accuracy of Fine Needle Cytology in Histological Prediction of Papillary Thyroid Carcinoma Variants: a Prospective Study Anna Cipolletta Campanile · Maria Gabriella Malzone · Nunzia Simona Losito · Gerardo Botti · Maria Grazia Chiofalo · Antongiulio Faggiano · Roberta Siciliano · Annamaria Colao · Luciano Pezzullo · Franco Fulciniti · Franco Fulciniti
Malignant Mucous Cells in a Thyroid Aspirate: Looking for a Source Sara Fontanella · Massimo Bongiovanni · Antoine Nobile · Silvia Uccella · Luca Mazzucchelli · Vittoria Espeli · Luca Giovanella · Luca Giovanella
Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression Ying-Hsia Chu · Ricardo V. Lloyd · Ricardo V. Lloyd
New Genetics and Genomic Data on Pancreatic Neuroendocrine Tumors: Implications for Diagnosis, Treatment, and Targeted Therapies Anja Schmitt · Ilaria Marinoni · Annika Blank · Aurel Perren · Aurel Perren
Detection of Molecular Alterations in Medullary Thyroid Carcinoma Using Next-Generation Sequencing: an Institutional Experience Shuanzeng Wei · Shuanzeng Wei · Virginia A. LiVolsi · Kathleen T. Montone · Jennifer J.D. Morrissette · Zubair W. Baloch · Zubair W. Baloch
Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma Bin Xu · Ronald Ghossein · Ronald Ghossein
Neuroendocrine Tumors of the Urinary Bladder According to the 2016 World Health Organization Classification: Molecular and Clinical Characteristics Erik Kouba · Liang Cheng · Liang Cheng
Detailed Lymph Node Sectioning of Papillary Thyroid Carcinoma Specimen Increases the Number of pN1a Patients Felix Haglund · Felix Haglund · Stina Garvin · Catharina Ihre-Lundgren · Inga-Lena Nilsson · Evelina Hall · Tobias Carling · Anders Höög · Anders Höög · C. Christofer Juhlin · C. Christofer Juhlin · C. Christofer Juhlin
Amyloid Goiter in a Patient with Progressive Thyromegaly Amber R. Wang · Zubair W. Baloch · Kathleen T. Montone · Kathleen T. Montone
Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index Hee Eun Lee · Taofic Mounajjed · Lori A. Erickson · Tsung Teh Wu · Tsung Teh Wu
Liver Metastases of Neuroendocrine Tumors Rarely Show Overlapping Immunoprofile with Hepatocellular Carcinomas Ming Jin · Xiao-Ping Zhou · Martha Yearsley · Wendy L. Frankel · Wendy L. Frankel
Expression of Somatostatin Receptor Type 2A and PTEN in Neuroendocrine Neoplasms Is Associated with Tumor Grade but Not with Site of Origin Hideo Wada · Katsuya Matsuda · Yuko Akazawa · Yuka Yamaguchi · Shiro Miura · Nozomi Ueki · Akira Kinoshita · Koh-ichiro Yoshiura · Hisayoshi Kondo · Masahiro Ito · Takeshi Nagayasu · Masahiro Nakashima · Masahiro Nakashima
A Novel Mutation in a Patient with Hyperparathyroidism-Jaw Tumour Syndrome Bellido · Larrañaga I · Guimón M · Martinez-Conde R · Eguia A · Perez de Nanclares G · Castaño L · Castaño L · Gaztambide S · Gaztambide S
Parathyroid Lipoadenoma: a Clinicopathological Diagnosis and Possible Trap for the Unaware Pathologist Hyrcza · Hyrcza · Sargın P · Ozgur Mete · Ozgur Mete · Ozgur Mete · Ozgur Mete
An Unusual Solitary Thyroid Nodule with Bloody Follicles: Metastatic Renal Cell Carcinoma Within an Infiltrative Follicular Variant Papillary Carcinoma Mehmet Kefeli · Ozgur Mete · Ozgur Mete · Ozgur Mete
Role of Histological Criteria and Immunohistochemical Markers in Predicting Risk of Malignancy in Parathyroid Neoplasms Niraj Kumari · Nandita Chaudhary · Roma Pradhan · Amit Agarwal · Narendra Krishnani · Narendra Krishnani
Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF V600E Harboring Pediatric Papillary Thyroid Carcinomas Semen Onder · Sule Ozturk Sari · Gulcin Yegen · İsmail Cem Sormaz · Ismail Yilmaz · Sukran Poyrazoglu · Yasemin Sanli · Yasemin Giles Senyurek · Yersu Kapran · Ozgur Mete · Ozgur Mete · Ozgur Mete
A Unique Case of Mediastinal Teratoma with Mature Pancreatic Tissue, Nesidioblastosis, and Aberrant Islet Differentiation: a Case Report and Literature Review Tanupriya Agrawal · Adam J. Blau · Walter J. Chwals · Arthur S. Tischler · Arthur S. Tischler
Thyreoglossal Duct Cyst with Evidence of Solid Cell Nests and Atypical Thyroid Follicles Marco Manzoni · Francesca Bono · Andrew Smith · Giovanni Cavenaghi · Werner Garavello · Fabio Pagni · Fabio Pagni
Bronchial Paraganglioma with SDHB Deficiency Maria-Rosa Ghigna · Peter Dorfmüller · Adrian Crutu · E. Fadel · V. Thomas de Montpréville · V. Thomas de Montpréville
Oncogene-Induced Senescence in Pituitary Adenomas-an Immunohistochemical Study Emilija Manojlovic-Gacic · Milica Skender-Gazibara · Vera Popovic · Ivan Soldatovic · Novica Boricic · Savo Raicevic · Sandra Pekic · Mirjana Doknic · Dragana Miljic · Irina Alafuzoff · Irina Alafuzoff · Fredrik Pontén · Olivera Casar-Borota · Olivera Casar-Borota · Olivera Casar-Borota
Non-Coding RNAs in Thyroid Cancer Ranran Zhang · Heather Hardin · Jidong Chen · Zhenying Guo · Ricardo V. Lloyd · Ricardo V. Lloyd
Clinical Impact of the Current WHO Classification of Pituitary Adenomas Wolfgang Saeger · Jürgen Honegger · Marily Theodoropoulou · U. J. Knappe · C. Schöfl · S. Petersenn · Rolf Buslei · Rolf Buslei
Unexpected Tumor: Primary Asymptomatic Schwannoma in Thyroid Gland Vázquez-Benítez G · Pérez-Campos A · Masgrau Na · Pérez-Barrios A · Pérez-Barrios A
Monomorphous Plurihormonal Pituitary Adenoma of Pit-1 Lineage in a Giant Adolescent with Central Hyperthyroidism Bernardo Dias Pereira · Luísa Raimundo · Ozgur Mete · Ana Oliveira · Jorge Portugal · Sylvia L. Asa · Sylvia L. Asa
Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms Stefano La Rosa · Fausto Sessa · Silvia Uccella · Silvia Uccella
The Value of HBME-1 and Claudin-1 Expression Profile in the Distinction of BRAF-Like and RAS-Like Phenotypes in Papillary Thyroid Carcinoma Hasan Gucer · Pelin Bağcı · Recep Bedir · Ibrahim Sehitoglu · Ozgur Mete · Ozgur Mete · Ozgur Mete · Ozgur Mete
Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification David S. Priemer · Rodolfo Montironi · Lisha Wang · Sean R. Williamson · Sean R. Williamson · Antonio Lopez-Beltran · Liang Cheng · Liang Cheng
A Calcitonin Non-producing Neuroendocrine Tumor of the Thyroid Gland Atsuko Kasajima · José Cameselle-Teijeiro · Lourdes Loidi · Yoshio Takahashi · Noriaki Nakashima · Satoko Sato · Fumiyoshi Fujishima · Mika Watanabe · Tadao Nakazawa · Hiroshi Naganuma · Tetsuo Kondo · Ryohei Kato · Hironobu Sasano · Hironobu Sasano
Hürthle Cells Adenoma of the Thyroid with Post-surgical Implants in the Neck: Clinical, Morphological, and Molecular Analysis of Three Cases Massimo Bongiovanni · Silvia Uccella · Luca Giovanella · Francesca Molinari · Milo Frattini · Gianlorenzo Dionigi · Eliana Piantanida · Antoine Nobile · Fausto Sessa · Stefano La Rosa · Stefano La Rosa
Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification Wolfgang Saeger · S. Petersenn · C. Schöfl · U. J. Knappe · Marily Theodoropoulou · Rolf Buslei · Jürgen Honegger · Jürgen Honegger
Pigmented Pheochromocytoma: an Unusual Variant of a Common Tumor Aanchal Kakkar · Kavneet Kaur · Tarun Kumar · Libin Babu Cherian · Rohit Kaushal · Mehar Chand Sharma · Anita Dhar · Amlesh Seth · Deepali Jain · Deepali Jain
Establishment and Characterization of a Human Neuroendocrine Tumor Xenograft Zhaoying Yang · Zhaoying Yang · Le Zhang · Le Zhang · Stefano Serra · Stefano Serra · Calvin Law · Calvin Law · Alice Wei · Alice Wei · Tracy L. Stockley · Tracy L. Stockley · Shereen Ezzat · Shereen Ezzat · Sylvia L. Asa · Sylvia L. Asa · Sylvia L. Asa
Epithelioid Hemangioendothelioma: a Rare Primary Thyroid Tumor with Confirmation of WWTR1 and CAMTA1 Rearrangements Akeesha A. Shah · N. Paul Ohori · Linwah Yip · Christopher Coyne · Cristina R. Antonescu · Raja R. Seethala · Raja R. Seethala
Targeted Next-Generation Sequencing Analysis of a Pendred Syndrome-Associated Thyroid Carcinoma Guo-Xia Tong · Qing Chang · Diane Hamele-Bena · John Carew · Richard S. Hoffman · Marina N. Nikiforova · Yuri E. Nikiforov · Yuri E. Nikiforov
Molecular Characterization of an Endometrial Endometrioid Adenocarcinoma Metastatic to a Thyroid Hürthle Cell Adenoma Showing Cancerization of Follicles Amir Afrogheh · Emily E. Meserve · Emily E. Meserve · Peter M. Sadow · Antonia E. Stephen · Vânia Nosé · Suzanne Berlin · William C. Faquin · William C. Faquin
Unusual Thyroid Carcinoma Metastases: a Case Series and Literature Review Eleonora Farina · Fabio Monari · Giovanni Tallini · Andrea Repaci · Renzo Mazzarotto · Francesca Giunchi · Riccardo Panzacchi · Silvia Cammelli · Gilbert D.A. Padula · F. Deodato · Renato Pasquali · Stefano Fanti · Michelangelo Fiorentino · A.G. Morganti · A.G. Morganti
Thyroid Solid Cell Nests: Usefulness of Cytokeratin 5/6? : Cytokeratin 5/6 in Thyroid Cell Nests Adriana Handra-Luca · Adriana Handra-Luca
STK11 Mutation Identified in Thyroid Carcinoma Shuanzeng Wei · Virginia A. LiVolsi · Marcia S. Brose · Kathleen T. Montone · Jennifer J.D. Morrissette · Zubair W. Baloch · Zubair W. Baloch
Hypoglycemic Syndrome without Hyperinsulinemia. A Diagnostic Challenge Belén Pérez-Pevida · Miguel Angel Idoate · Sara Fernández-Landázuri · Nerea Varo · Javier Escalada · Javier Escalada
Should Core Needle Biopsy be Used in the Evaluation of Thyroid Nodules Beril Guler · Tugce Kiran · Dilek Sema Arici · Erhan Aysan · Fatma Cavide Sonmez · Fatma Cavide Sonmez
The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors Ozturk Sari S · Taskin Oc · Gundogdu G · Gulcin Yegen · Semen Onder · Keskin M · Saglam S · Ozluk Y · Gulluoglu M · Ozgur Mete · Ozgur Mete · Ozgur Mete
Critical Pitfalls in the use of BRAF Mutation as a Diagnostic Tool in Thyroid Nodules: a Case Report Elisabetta Kuhn · Moira Ragazzi · Michele Zini · Davide Giordano · Davide Nicoli · Simonetta Piana · Simonetta Piana
Comparing Clinicopathologic and Radiographic Findings Between TT-UMP, Classical, and Non-Encapsulated Follicular Variants of Papillary Thyroid Carcinomas Husniye Baser · Oya Topaloglu · Abbas Ali Tam · Afra Alkan · Aydan Kilicarslan · Reyhan Ersoy · Bekir Cakir · Bekir Cakir
Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome Sounak Gupta · Jun Zhang · Michael Rivera · Lori A. Erickson · Lori A. Erickson
Synchronous Papillary Carcinoma of Thyroid and Lung Tao Wang · Ian Blumer · Scott L. Boerner · Sylvia L. Asa · Sylvia L. Asa
Reliability of Ki-67 Determination in FNA Samples for Grading Pancreatic Neuroendocrine Tumors Cristina Díaz del Arco · J. Ángel Díaz Pérez · Luis Ortega Medina · Javier Sastre Valera · M. Jesús Fernández Aceñero · M. Jesús Fernández Aceñero
Stage-Specific Embryonic Antigen-1 (SSEA-1) Expression in Thyroid Tissues Jin Xu · Heather Hardin · Ranran Zhang · Kaitlin Sundling · Darya Buehler · Ricardo V. Lloyd · Ricardo V. Lloyd
A Case of Cushings Syndrome with Multiple Adrenocortical Adenomas Composed of Compact Cells and Clear Cells Masahiro Asakawa · Takanobu Yoshimoto · Mitsutane Ota · Mitsuyuki Numasawa · Yuriko Sasahara · Takato Takeuchi · Yujiro Nakano · Norihiko Oohara · Masanori Murakami · Ryotaro Bouchi · Isao Minami · Kyoichiro Tsuchiya · Koshi Hashimoto · Hajime Izumiyama · Naoko Kawamura · Kazunori Kihara · Mariko Negi · Takumi Akashi · Yoshinobu Eishi · Hironobu Sasano · Yoshihiro Ogawa · Yoshihiro Ogawa

Fit-for-Purpose Immunohistochemical Biomarkers
Endocrine Pathology | 2018
Emina Torlakovic · Emina Torlakovic · Emina Torlakovic
Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms
Endocrine Pathology | 2018
Ozgur Mete · Sylvia L. Asa · Thomas J. Giordano · Mauro Papotti · Hironobu Sasano · Marco Volante · Marco Volante
RNA-Seq Analysis of Islets to Characterise the Dedifferentiation in Type 2 Diabetes Model Mice db/db
Endocrine Pathology | 2018
Abraham Neelankal John · Abraham Neelankal John · Ramesh Ram · Fang-Xu Jiang · Fang-Xu Jiang